Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
Virology Journal|October 30, 2021
Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infectionHind Hamzeh-Cognasse, Alexandre Mansour, Florian Reizine, et al.Studies in Health Technology and Informatics|August 23, 2024
Applying Machine Learning for Prescriptive Support: A Use Case with Unfractionated Heparin in Intensive Care UnitsBoris Delange, Guillaume Bouzille, Isabelle Gouin, et al.Annales De Biologie Clinique|January 31, 2017
Impact of a pneumatic tube system transport on hemostasis parameters measurement: the experiment of Cochin universitary hospital (AP-HP, Paris, France)Leyla Calmette, Firas Ibrahim, Isabelle Gouin, et al.Pharmaceutics|February 25, 2023
Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External EvaluationsCyril Leven, Pauline Ménard, Isabelle Gouin-Thibault, et al.Journal of Clinical Laboratory Analysis|July 11, 2023
A performance evaluation of sthemO 301 coagulation analyzer and associated reagentsAdeline Pontis, Mélanie Delanoe, Nathalie Schilliger, et al.European Journal of Anaesthesiology|August 11, 2015
Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional studyClaude Lentschener, Claire Flaujac, Firas Ibrahim, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 11, 2015
Prevalence of Hereditary Thrombophilia in Patients Older Than 75 Years With Venous Thromboembolism Referred for Thrombophilia ScreeningVirginie Siguret, Joseph Emmerich, Tiphaine Belleville, et al.Annales De Biologie Clinique|August 6, 2016
PT, aPTT, TT and the hemostatic safety threshold of dabigatran and rivaroxabanFiras Ibrahim, Leyla Calmette, Ayham Layka, et al.Presse Medicale (Paris, France : 1983)|April 26, 2011
[Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study]Isabelle Gouin-Thibault, François Liard, Eric Van-Ganse, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 15, 2007
Is Modification of Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin?Isabelle Gouin-Thibault, Eric Pautas, Isabelle Mahé, et al.Pageof 10